Data protection Impressum

Personalized Medicine

HeroSupport and Calico Biosystems join Tech4Eva, a six-month equity-free accelerator dedicated to advancing women’s health technologies globally.

HeroSupport and Calico Biosystems selected for the Tech4Eva accelerator program

15 May 2024

Takeda will receive an exclusive option to license AC Immune's ACI-24.060, a breakthrough therapy to combat the progression of Alzheimer's disease, for an upfront payment of USD 100 million and potential milestone payments of USD 2.1 billion.

AC Immune and Takeda sign USD 100 million deal to treat Alzheimer’s disease

13 May 2024

Testmate Health, a Lausanne-based start-up, has successfully raised USD 6 million to advance the development and commercialization of their at-home rapid test kits for sexually transmitted infections (STIs).

Testmate Health raises USD 6 million to combat STIs with innovative home testing kits

8 May 2024

Bernese medtech machineMD and Oxford-based gaitQ have jointly received a million-dollar research grant from InnovateUK and Innosuisse, aimed at enhancing the monitoring and early detection of Parkinson's disease.

machineMD and gaitQ awarded grant for Parkinson’s research in the UK and Switzerland

7 May 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2024)

30 April 2024

The FIF has once again highlighted its commitment to propelling tech innovation in Geneva by awarding significant financial support to three promising projects.

Business environment

Azure Cell Therapies, FireFly Fusion and Antion Biosciences receive FIF support

29 April 2024

Isospec Analytics, a Vaud-based start-up specializing in biomolecular analysis, has secured USD 1.9 million in pre-seed funding to advance its revolutionary diagnostic technologies.

Isospec pioneers rapid diagnostic technologies with USD 1.9 million funding

22 April 2024

This initiative reflects a broader shift towards life sciences, driven by innovation and a commitment to health, wellness, and sustainability.

The HES-SO strengthens life sciences education and research in the canton of Valais

22 April 2024

Vaud-based biopharma Oculis has secured USD 59 million to extend operations into 2026, following a successful listing on NASDAQ Iceland Main Market.

Oculis announces completion of oversubscribed USD 59 million registered direct offering

15 April 2024

Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment through 3D printing.

Swibrace advances to clinical phase with innovative 3D-printed wrist braces

15 April 2024

1 2 3 4 5 6 7 … 15